Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis
about
Ketogenic diet in neuromuscular and neurodegenerative diseasesSevere loss of appetite in amyotrophic lateral sclerosis patients: online self-assessment studyComplementary and Alternative Therapies in Amyotrophic Lateral SclerosisClinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosisBlood Cell Palmitoleate-Palmitate Ratio Is an Independent Prognostic Factor for Amyotrophic Lateral SclerosisBeing PRO-ACTive: What can a Clinical Trial Database Reveal About ALS?The PRO-ACT database: design, initial analyses, and predictive featuresA randomized, double blind, placebo-controlled trial of pioglitazone in combination with riluzole in amyotrophic lateral sclerosisComprehensive rehabilitative care across the spectrum of amyotrophic lateral sclerosis.Rehabilitation in amyotrophic lateral sclerosis: why it mattersAmyotrophic Lateral Sclerosis Survival Score (ALS-SS): A simple scoring system for early prediction of patient survival.Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progression.Association Between Change in Body Mass Index, Unified Parkinson's Disease Rating Scale Scores, and Survival Among Persons With Parkinson Disease: Secondary Analysis of Longitudinal Data From NINDS Exploratory Trials in Parkinson Disease Long-term SPredicting functional decline and survival in amyotrophic lateral sclerosis.Adipokines, C-reactive protein and Amyotrophic Lateral Sclerosis - results from a population- based ALS registry in Germany.Inhibition of β-Glucocerebrosidase Activity Preserves Motor Unit Integrity in a Mouse Model of Amyotrophic Lateral Sclerosis.Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trialMechanisms, models and biomarkers in amyotrophic lateral sclerosisHDL and cognition in neurodegenerative disorders.Adipose Tissue Distribution Predicts Survival in Amyotrophic Lateral SclerosisWeight loss, dysphagia and supplement intake in patients with amyotrophic lateral sclerosis (ALS): impact on quality of life and therapeutic options.Survey of current enteral nutrition practices in treatment of amyotrophic lateral sclerosisTrials of antidiabetic drugs in amyotrophic lateral sclerosis: proceed with caution?Palliative Care Issues in Amyotrophic Lateral Sclerosis: An Evidenced-Based Review.Uric acid levels predict survival in men with amyotrophic lateral sclerosis.Prognostic Factors in Amyotrophic Lateral Sclerosis: A Population-Based StudyMeasurement of cystatin C levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.Pre-morbid type 2 diabetes mellitus is not a prognostic factor in amyotrophic lateral sclerosisAmyotrophic lateral sclerosis: update and new developments.Resentment, hate, and hope in amyotrophic lateral sclerosisPrediagnostic body fat and risk of death from amyotrophic lateral sclerosis: the EPIC cohort.Antecedent Disease and Amyotrophic Lateral Sclerosis: What Is Protecting Whom?Premorbid body mass index and risk of amyotrophic lateral sclerosisDiabetes Mellitus, Obesity, and Diagnosis of Amyotrophic Lateral Sclerosis: A Population-Based Study.Symptom Management and End-of-Life Care in Amyotrophic Lateral Sclerosis.A plural role for lipids in motor neuron diseases: energy, signaling and structure.Estimating daily energy expenditure in individuals with amyotrophic lateral sclerosis.High-fat and ketogenic diets in amyotrophic lateral sclerosis.New therapy options for amyotrophic lateral sclerosis.The serum lipid profiles of amyotrophic lateral sclerosis patients: A study from south-west China and a meta-analysis.
P2860
Q21284703-839B57D8-BFDB-4C72-A64B-2B4C7D09CEE3Q22305776-F34CCA1F-698A-4087-8BD1-4EFB0066559AQ26777929-C6261FAF-936E-4EF0-981F-0E65BB2022FFQ28392768-8BA002E8-5E0A-4A16-A821-A091BE25C710Q28546154-20DBD2AA-1572-4759-A920-4F373D63C752Q28649394-433AB468-103F-4AD8-AB8E-EA9034BA0DA0Q28651661-DF39E557-8BB3-4C98-A625-3E492CE2832CQ28728672-6FAEEDB6-8EB2-4275-BE7E-3B956A688B33Q30365902-7EA78795-53A1-4457-9C85-9A725E743825Q30407969-97722630-B739-4EE4-BDA8-6D49E222FE7CQ30488423-5B692162-D17C-446C-AB20-0754AAABE424Q30866592-1ECB8DEA-01B9-4E7B-A608-FCF3FC205D46Q31036167-AEDB7D97-39F8-4C93-9FAE-2B108777BAEFQ33562655-D1A24A3A-4999-4BCC-B95D-53D5DD24A414Q33854270-8538CB56-2CE8-4066-91C5-4904BBB97D3BQ33899405-FE956A71-DD88-4C6F-B822-BFDF0CAD9A1BQ34251334-A9D21C06-DB8C-49A0-A8B3-720B2EC7FD53Q34344992-3D9EED33-240E-4FC9-9457-A58FC328C348Q34614842-06274896-DB7E-4506-96EC-E0FC7AEB8F4BQ34797530-6586D23A-5D3E-4F0C-AE7A-65E43CC9E88FQ34815254-31F24A9D-E2B4-4BEE-91F8-D6CDD58A6D6EQ34820824-94F21458-302E-47C2-8160-EE8652526FE9Q35618724-2E3A9430-54E0-4B52-9547-87E4B874531DQ35630224-DB5FAA01-1726-446A-859A-C1B9DA97EE67Q35638492-9A498B60-1DA9-4F0B-AB5D-A5613772E0FEQ35827095-9CC19A2B-C9AC-426C-B0DD-1E21F57B410EQ35854192-F2A88547-D576-4F25-B3CA-2EC46496EC5EQ35952241-7803305E-B98D-4DB4-8FEE-57E51C5D2CE8Q36278310-B92D783D-C668-4649-8335-EED9BF43206BQ36424983-47ADF12D-818F-4A3A-99E3-045D929790CAQ36687156-18C97206-6284-4C11-A257-99AB90E51821Q36735465-5F980971-C7B3-440B-B862-C7977ED05736Q36737158-331A51B5-E33A-48A0-8FCF-1C80323BED13Q37155949-529D46FB-69F7-4628-A15D-0A9D64FD3345Q37272856-67A8B0B1-B802-4432-A563-EFE31C3652A4Q37594297-DA335133-8E58-450E-A69C-DB2C80E2AC74Q37636674-00900DA6-E9ED-46F3-A8E8-2C0958B95528Q38105917-C8E6013A-8A92-4BE5-8F69-4B724CD27AB5Q38121637-4EC7CE99-44F6-41A6-9138-3FAB44EEC54BQ38539827-B473DE01-58F7-42A3-A9C4-A36F4B7F9EA5
P2860
Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Body mass index, not dyslipide ...... amyotrophic lateral sclerosis
@ast
Body mass index, not dyslipide ...... amyotrophic lateral sclerosis
@en
Body mass index, not dyslipide ...... amyotrophic lateral sclerosis
@nl
type
label
Body mass index, not dyslipide ...... amyotrophic lateral sclerosis
@ast
Body mass index, not dyslipide ...... amyotrophic lateral sclerosis
@en
Body mass index, not dyslipide ...... amyotrophic lateral sclerosis
@nl
prefLabel
Body mass index, not dyslipide ...... amyotrophic lateral sclerosis
@ast
Body mass index, not dyslipide ...... amyotrophic lateral sclerosis
@en
Body mass index, not dyslipide ...... amyotrophic lateral sclerosis
@nl
P2093
P2860
P356
P1433
P1476
Body mass index, not dyslipide ...... amyotrophic lateral sclerosis
@en
P2093
Anne-Marie Wills
Matthew Jaffa
Sabrina Paganoni
P2860
P356
10.1002/MUS.22114
P577
2011-05-23T00:00:00Z